Skip to main content
. Author manuscript; available in PMC: 2012 Nov 15.
Published in final edited form as: Cancer. 2011 Jun 3;117(22):5039–5046. doi: 10.1002/cncr.26169

Table 2.

Results of survival analysis of CAPRA-S score, both as a continuous and a categorized variable, illustrating number (N) and % of patients at each score, and the hazard ratio (HR) for progression given with the bootstrap-corrected 95% confidence interval (95%CI) for the HR. Comparisons are given at each CAPRA-S score level relative to CAPRA-S 0 and relative to the prior score (i.e. CAPRA-S 1 vs 0, 2 vs 1, etc.). Actuarial progression-free probability at each score level at 3 and 5 years is given with 95% CI. NS = not significant.

CAPRA-S N (%) Comparison to CAPRA-S 0 Comparison to prior level Progression-free probability (95% CI)
HR (95% CI) P HR (95% CI) P 3-year 5-year
(continuous) 3787 1.54 (1.50–1.59) <0.001

0 1042 (27.2) ref 96.3 (94.8 97.4) 94.5 (92.3 96.1)
1 826 (21.5) 1.59 (1.06–2.39) 0.024 1.59 (1.06–2.38) 0.024 95.3 (93.2 96.7) 91.0 (87.7 93.4)
2 669 (17.4) 3.39 (2.34–4.90) <0.001 2.12 (1.54–2.94) <0.001 89.8 (86.9 92.1) 83.3 (79.2 86.6)

3 499 (13.0) 6.01 (4.18–8.63) <0.001 1.77 (1.35–2.33) <0.001 80.7 (76.5 84.3) 72.8 (67.5 77.3)
4 336 (8.8) 6.77 (4.57–10.0) <0.001 1.13 (0.84–1.51) NS 74.9 (69.3 79.6) 70.2 (63.9 75.5)
5 213 (5.6) 13.0 (9.01–18.8) <0.001 1.92 (1.43–2.58) <0.001 63.1 (55.5 69.8) 42.5 (33.4 51.3)

6 103 (2.7) 18.9 (12.7–28.0) <0.001 1.45 (1.06–1.98) 0.023 49.2 (38.3 59.2) 25.9 (16.0 36.9)
7 70 (1.8) 19.5 (12.5–30.5) <0.001 1.03 (0.67–1.59) NS 50.9 (37.5 62.8) 26.9 (15.5 39.7)
8 40 (1.0) 33.4 (20.9–53.5) <0.001 1.71 (1.03–2.82) 0.026 26.9 (12.8 43.2) 12.3 (2.8 29.4)
≥9 39 (1.0) 64.2 (40.5–101) <0.001 1.92 (1.18–3.12) 0.01 7.3 (1.4 19.9) 0